Is it true that trans fats raise LDL cholesterol and lower HDL cholesterol?

Supported by Evidence

The claim that trans fats raise LDL cholesterol and lower HDL cholesterol is one of the most consistently supported findings in…

Evidence base: Systematic reviews and RCTs · Source-backed · 4 verified PubMed citations · Last verified July 7, 2026

The claim that trans fats raise LDL cholesterol and lower HDL cholesterol is one of the most consistently supported findings in nutritional biochemistry, particularly for industrially produced trans fatty acids (iTFA) created through partial hydrogenation of vegetable oils. Multiple systematic reviews, meta-analyses, and controlled dietary intervention trials have demonstrated this dual adverse effect on the lipid profile. The mechanism involves iTFA interfering with LDL receptor activity (raising LDL) while simultaneously reducing apolipoprotein A-I and HDL particle function (lowering HDL) — a combination uniquely harmful compared to saturated fats, which raise LDL but do not lower HDL to the same degree. This evidence base underpins global regulatory action to eliminate iTFA from food supplies.

An important nuance is that not all trans fats behave identically. Naturally occurring ruminant trans fatty acids (rTFA), such as vaccenic acid and conjugated linoleic acid found in dairy and meat from ruminant animals, appear to have a more neutral or even modestly beneficial cardiometabolic profile compared to iTFA. One systematic review found that both rTFA and iTFA can adversely affect lipid profiles, but the effect of rTFA may differ depending on dose and population. A separate meta-analysis of RCTs specifically examining dairy-derived TFA found no significant adverse effect on blood lipids or cardiometabolic disease risk, supporting the distinction between industrial and ruminant trans fats. This distinction is critical for interpreting the broader claim.

The high-oleic oil substitution literature also corroborates the claim indirectly: replacing TFA-containing oils with high-oleic alternatives significantly reduces LDL cholesterol, confirming that iTFA elevation of LDL is a real and reversible dietary effect. Overall, while the claim is an accurate characterization of industrially produced trans fats specifically, it should be understood as applying primarily to iTFA rather than all trans fats universally.

Worth knowing

  • The LDL-raising and HDL-lowering effects apply most clearly to industrially produced trans fats (iTFA) from partial hydrogenation; naturally occurring ruminant trans fats (e.g., from dairy) appear to have a more neutral cardiometabolic profile.
  • The dual effect of raising LDL while also lowering HDL makes iTFA particularly harmful compared to saturated fats, which primarily raise LDL without consistently lowering HDL.
  • Most developed countries have now implemented regulatory limits or bans on iTFA, making dietary exposure from traditional sources much lower than in earlier decades — context matters for current public health relevance.

Supporting research

Every citation is a real, verified PubMed record — see how verdicts are rated.

Check any nutrition claim yourself

Verdik checks claims against verified PubMed research and shows you the sources — including the ones that disagree.

Download Verdik Free

Related claims

Verdik verdicts are educational information about nutrition research, not medical advice. Verdicts summarize source-backed evidence at the time of review and are not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider about your diet, supplements, or medical conditions. Read about how our verdict scale works, or check any claim yourself in the Verdik app.